ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2009

Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's disease.

Jacobus P Petzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.